Search





Search





Markets
/
Stocks
/
idya
/

IDEAYA Biosciences Inc

IDYA

Add to Watchlist

35.500USD

-0.900-2.47%

Close 07-31 16:00（ET）Quotes delayed by 15 min

3.38BMarket Cap

LossP/E TTM

IDEAYA Biosciences Inc

35.500

-0.900-2.47%

Overview

Financials

Discussions

Analysis

Company

View Detailed Chart

TradingKey Chart

Intraday

30m

Today

-2.47%

5 Days

+0.28%

1 Month

-1.85%

6 Months

+10.28%

Year to Date

+2.69%

1 Year

+46.27%

Key Figures

36.370Open

36.630High

481.99KVolume

LossP/E TTM

LossP/E Dynamic

--Dividend TTM

0.55%Turnover Ratio

36.400Prev. Close

35.290Low

14.11MTurnover

LossP/E Static

3.33P/B

0.00%Div Yield TTM

-13.14%ROA

39.28052wk High

0.60Volume Ratio

-274.48MNet Profit

87.86MShares

-1.5790EPS TTM

-0.05Beta

-14.28%ROE

19.26052wk Low

3.68%Amplitude

100.00%Gross Margin

3.38BMarket Cap

-2.66Reward/Risk

2.83%Risk Rate

TradingKey Stock Score of IDEAYA Biosciences Inc

Currency: USD Updated: 2026-07-31

Key Insights

IDEAYA Biosciences Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 65 out of 385 in the Biotechnology & Medical Research industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 53.62.In the medium term, the stock price is expected to trend up.The company has shown weak stock market performance over the past month, in line with its weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

IDEAYA Biosciences Inc's Score

Industry at a Glance

Industry Ranking

65 / 385

Overall Ranking

140 / 4281

Industry

Biotechnology & Medical Research

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score

Previous score

Media Coverage

Last 24 hours

Coverage Level

Very Low

Very High

Positive

IDEAYA Biosciences Inc Highlights

StrengthsRisks

IDEAYA Biosciences, Inc. is a precision medicine oncology company. The Company is engaged in the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. Its lead product candidates include darovasertib (PKC), IDE397 (MAT2A), IDE849 (DLL3), IDE275 / GSK959 (Werner Helicase), IDE161 (PARG), and IDE705 / GSK101 (Pol Theta Helicase). IDE196, a small-molecule protein kinase C (PKC) inhibitor, in combination with crizotinib, an investigational cMET inhibitor. IDE397 is its small-molecule methionine adenosyltransferase 2a (MAT2A) inhibitor. IDE275 (GSK959) Werner Helicase (WRN) inhibitor for patients having tumors with MSI-High. IDE161 (PARG) is a small-molecule poly (ADP-ribose) glycohydrolase, or PARG, inhibitor. IDE705 is a small-molecule inhibitor of Pol Theta Helicase, in combination with niraparib, the GSK small-molecule inhibitor of poly-(ADP-ribose) polymerase (PARP).

High Growth

The company's revenue has grown steadily over the past 3 years, averaging 835.26% year-on-year.

Undervalued

The company’s latest PE is -22.48, at a low 3-year percentile range.

Institutional Selling

The latest institutional holdings are 97.55M shares, decreasing 11.71% quarter-over-quarter.

Held by ETHSX

Star Investor ETHSX holds 438.18K shares of this stock.

Analyst Rating

Based on 16 analysts

Buy

Current Rating

53.615

Target Price

+50.65%

Upside Space

IDEAYA Biosciences Inc News

More news coming soon, stay tuned...

Earnings Forecast

Analyst Rating

Based on 16 analysts

Buy

Current Rating

53.615

Target Price

+50.65%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

496

Total

Median

Average

Company name

Ratings

Analysts

IDEAYA Biosciences Inc

IDYA

Beigene Ltd

ONC

argenx SE

ARGX

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

Insmed Inc

INSM

...

Indicators

Indicators

Sell(3)

Neutral(4)

Buy(0)

Indicators

Value

Direction

MACD(12,26,9)

-0.578

Neutral

RSI(14)

49.994

Neutral

STOCH(KDJ)(9,3,3)

46.484

Neutral

ATR(14)

1.399

High Vlolatility

CCI(14)

-47.143

Neutral

Williams %R

61.697

Sell

TRIX(12,20)

0.166

Sell

StochRSI(14)

0.000

Sell

Moving Average

Sell(3)

Neutral(0)

Buy(3)

Indicators

Value

Direction

MA5

36.084

Sell

MA10

35.849

Sell

MA20

36.604

Sell

MA50

33.498

Buy

MA100

32.271

Buy

MA200

32.737

Buy

Financial Indicators

EPS

Relevant data have not been disclosed by the company yet.

Total revenue

Relevant data have not been disclosed by the company yet.

IDEAYA Biosciences Inc Info

Ticker SymbolIDYA

CompanyIDEAYA Biosciences Inc

CEOHata (Yujiro S)

Websitehttps://www.ideayabio.com/

Shareholders

Shareholders

Proportion

Fidelity Management & Research Company LLC

14.97%

Janus Henderson Investors

8.18%

BlackRock Institutional Trust Company, N.A.

7.45%

Capital Research Global Investors

6.01%

State Street Investment Management (US)

4.71%

Other

58.69%

Popular Instruments

FAQs

What is the current price of IDEAYA Biosciences Inc (IDYA)?



The current price of IDEAYA Biosciences Inc (IDYA) is 35.50.

What is the symbol of IDEAYA Biosciences Inc?



The ticker symbol of IDEAYA Biosciences Inc is IDYA.

What is the 52-week high of IDEAYA Biosciences Inc?



The 52-week high of IDEAYA Biosciences Inc is 39.28.

What is the 52-week low of IDEAYA Biosciences Inc?



The 52-week low of IDEAYA Biosciences Inc is 19.26.

What is the market capitalization of IDEAYA Biosciences Inc?



The market capitalization of IDEAYA Biosciences Inc is 3.12B.

Is IDEAYA Biosciences Inc (IDYA) currently rated as Buy, Hold, or Sell?



According to analysts, IDEAYA Biosciences Inc (IDYA) has an overall rating of Buy, with a price target of 53.62.

What is the Earnings Per Share (EPS TTM) of IDEAYA Biosciences Inc (IDYA)?



The Earnings Per Share (EPS TTM) of IDEAYA Biosciences Inc (IDYA) is -1.28.